Pharmacogenetics Test (PGx)

Variability in patient’s response to drugs treatment represents a major challenge to doctors as one drug doesn’t suit all. This variability occurs as a result of differential genetic traits that are present in an individual. Each person has uniqueness in how his body interacts with administered drugs. In some individuals it may lead to significant drug toxicities and/ or risk of drug efficacy which becomes even more important when drugs are prescribed for longer time duration.

The majority of known adverse drug reactions (ADRs), 60% approximately, are triggered via exposure to drugs that are metabolized by liver enzymes with altered functions; induced by genetic mutations. Implementation of PGX testing has the potential to prevent occurrence of serious drugs related events; in some case leading to death.

Pharmacogenetic tests (PGx) is a onetime test, which provides an insight of genes responsible for metabolism of the drugs and suggest therapeutic intervention or modification such as increasing or decreasing drug  dose, stopping the drug or using an alternative drug suitable for an individual. We will have a personalized prescription for an individual ensuring efficacy and no adverse effects.

PGx is playing a fundamental role in the treatment outcome of diseases such as cancer, human immunodeficiency virus (HIV), heart disease, and hypertension. In US majority of healthcare insurance companies have stated special policies covering PGx testing. Poor medication adherence is a well-known problem, particularly in patients with chronic conditions, and is associated with significant morbidity, mortality, and health care costs. Multifaceted and personalized interventions have shown the greatest success. Pharmacogenetic (PGx) testing may serve as another tool to boost patients’ confidence in the safety and efficacy of prescribed medications. This will take care of Burdon on patients, hospitals as well as insurance companies.